Impact of Vitamin D Status and Obesity on C-Reactive Protein in Kidney-Transplant Patients

Journal of Renal Nutrition

Volumn 18, Issue 3, 2008, Pages 294-300

  Ewers, Bettina ^a   Gasbjerg, Ane ^a   Zerahn, Bo ^a   Marckmann, Peter ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DRUG DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; BODY MASS; COMORBIDITY; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; METHODOLOGY; MIDDLE AGED; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; RISK FACTOR; SEX RATIO; STATISTICS; VITAMIN D DEFICIENCY;

ADULT; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; COMORBIDITY; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; OBESITY; RISK FACTORS; SEX DISTRIBUTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 41849101469     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.11.004     Document Type: Article

References (34)

1. Gonzalez E.A., Sachdeva A., Oliver D.A., et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24 (2004) 503-510
2. Ishimura E., Nishizawa Y., Inaba M., et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55 (1999) 1019-1027
3. Ewers B., Gasbjerg G., Moelgaard C., et al. Vitamin D status in kidney transplant patients: Need for intensified routine supplementation. Am J Clin Nutr 87 (2008) 431-437
4. Querings K., Girndt M., Geisel J., et al. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab 91 (2006) 526-529
5. Lomonte C., Antonelli M., Vernaglione L., et al. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?. J Nephrol 18 (2005) 96-101
6. Heaf J., Tvedegaard E., Kanstrup I.L., et al. Bone loss after renal transplantation: Role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14 (2000) 457-463
7. Caravaca F., Fernandez M.A., Cubero J., et al. Are plasma 1,25-dihydroxyvitamin D3 concentrations appropriate after successful kidney transplantation?. Nephrol Dial Transplant 13 suppl 3 (1998) 91-93
8. Patel S., Farragher T., Berry J., et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56 (2007) 2143-2149
9. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 65 (2006) 593-597
10. Muller K., Haahr P.M., Diamant M., et al. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4 (1992) 506-512
11. Cohen-Lahav M., Douvdevani A., Chaimovitz C., et al. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 103 (2007) 558-562
12. Seibert E., Levin N.W., and Kuhlmann M.K. Immunomodulating effects of vitamin D analogs in hemodialysis patients. Hemodial Int 9 suppl 1 (2005) S25-S29
13. Nankivell B.J., and Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 81 (2006) 643-654
14. Hak E., Stehouwer C.D.A., Bots M.L., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy middle-aged women. Arterioscler Thromb Vasc Biol 19 (1999) 1986-1991
15. Festa A., D'Agostino Jr. R., Williams K., et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25 (2001) 1407-1415
16. Menon V., Wang X., Greene T., et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 42 (2003) 44-52
17. van Ree R.M., de Vries A.P., Oterdoom L.H., et al. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. Nephrol Dial Transplant 20 (2005) 2524-2531
18. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 suppl (2003) S1-201
19. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
20. Haran N., Gurwicz S., Gallati H., et al. Effect of 1 alpha-hydroxyvitamin D3 treatment on production of tumor necrosis factor-alpha by peripheral blood mononuclear cells and on serum concentrations of soluble tumor necrosis factor receptors in hemodialysis patients. Nephron 66 (1994) 262-266
21. Shoji T., Shinohara K., Kimoto E., et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19 (2004) 179-184
22. Adorini L., Amuchastegui S., and Daniel K.C. Prevention of chronic allograft rejection by vitamin D receptor agonists. Immunol Lett 100 (2005) 34-41
23. Mendall M.A., Patel P., Ballam L., et al. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. Br Med J [Clin Res] 312 (1996) 1061-1065
24. Tracy R.P., Psaty B.M., Macy E., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17 (1997) 2167-2176
25. Stuveling E.M., Hillege H.L., Bakker S.J., et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63 (2003) 654-661
26. El-Agroudy A.E., Wafa E.W., Gheith O.E., et al. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 77 (2004) 1381-1385
27. Meier-Kriesche H.U., Arndorfer J.A., and Kaplan B. The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 73 (2002) 70-74
28. Modlin C.S., Flechner S.M., Goormastic M., et al. Should obese patients lose weight before receiving a kidney transplant?. Transplantation 64 (1997) 599-604
29. Johnson D.W., Isbel N.M., Brown A.M., et al. The effect of obesity on renal transplant outcomes. Transplantation 74 (2002) 675-681
30. Aalten J., Christiaans M.H., de Fijter H., et al. The influence of obesity on short- and long-term graft and patient survival after renal transplantation. Transplant Int 19 (2006) 901-907
31. Isiklar I., Akin O., Demirag A., et al. Effects of renal transplantation on body composition. Transplant Proc 30 (1998) 831-832
32. Ducloux D., Kazory A., and Chalopin J.M. Predicting coronary heart disease in renal transplant recipients: A prospective study. Kidney Int 66 (2004) 441-447
33. Winkelmayer W.C., Lorenz M., Kramar R., et al. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant 4 (2004) 1148-1154
34. Winkelmayer W.C., Schaeffner E.S., Chandraker A., et al. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transplant Int 20 (2007) 505-511